ArticleJournal of clinical immunology2023
Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies.
Niraj C Patel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.